Modulators of cell adhesion, methods and compositions therefor
Compounds with activity as modulators of cell adhesion are disclosed. The compounds are derivatives of piperidin-4-amine. In some embodiments, a compound can be linked to a targeting agent, a pharmaceutically active substance and/or a support material. Methods for enhancing or inhibiting classical cadherin-mediated functions are also disclosed. The compounds can be used for the treatment or prevention of a variety of diseases including cancer. Compositions and devices, including skin patches comprising a compound are also disclosed. In addition, methods of synthesis of the compounds are provided.
1. A compound or pharmaceutically acceptable salt thereof, wherein the compound is (S)-1-(3,4-dichlorophenoxy)-3-(4-(((S)-2-hydroxy-3-(4-methoxyphenoxy)propyl)amino)piperidin-1-yl)propan-2-ol
2. A composition comprising:
the compound or a pharmaceutically acceptable salt thereof in accordance with claim 1 ; and a pharmaceutically acceptable carrier, excipient or diluent.
3. A composition in accordance with claim 2 , further comprising a heterologous compound selected from the group consisting of a pharmaceutically active substance, a detectable marker and a solid support.
4. A composition in accordance with claim 3 , wherein the pharmaceutically active substance is selected from the group consisting of an analgesic, an anesthetic, an antianginal, an antifungal, an antibiotic, an anticancer drug, an anti-inflammatory, an anthelmintic, an antidepressant, an antidote, an antiemetic, an antihistamine, an antihypertensive, an antimalarial, an antimicrotubule agent, an antimigraine agent, an antimicrobial, an antipsychotic, an antipyretic, an antiseptic, an anti-signaling agent, an antiarthritic, an antithrombin agent, an antituberculotic, an antitussive, an antiviral, an appetite suppressant, a cardioactive drug, a chemical dependency drug, a cathartic, a chemotherapeutic agent, a coronary vasodilator, a cerebral vasodilator, a peripheral vasodilator, a contraceptive agent, depressants, a diuretic, an expectorant, a growth factor, a hormonal agent, a hypnotic, an immunosuppression agent, an immunostimulatory agent, a narcotic antagonist, a parasympathomimetic, a sedative, a stimulant, a sympathomimetic, a toxin, a tranquilizer and a urinary anti-infective.
5. A composition in accordance with claim 2 , wherein the detectable marker is selected from the group consisting of a polypeptide antigen that can be detected with an antibody and an enzyme that can be detected with a chromogenic substrate or a fluorogenic substrate.
6. A composition in accordance with claim 2 , further comprising a solid support.
7. A composition in accordance with claim 6 , wherein the solid support is a polymeric matrix.
8. A patch for transdermal drug delivery, comprising:
a matrix; and
the compound or pharmaceutically acceptable salt thereof of claim 1 .
9. A patch for transdermal drug delivery in accordance with claim 8 , further comprising at least one additional pharmaceutical agent.
10. A patch for transdermal delivery in accordance with claim 9 , wherein the at least one additional pharmaceutical agent is selected from the group consisting of an anti-inflammatory drug, an analgesic, an antibiotic, an anticoagulant, an antidepressant, an antihypertensive drug, an antipsychotic drug, a sedative and a steroid.